ALDOX

This brand name is authorized in Nigeria.

Active ingredients

The drug ALDOX contains one active pharmaceutical ingredient (API):

1	Doxycycline UNII 19XTS3T51U - DOXYCYCLINE HYCLATE
	Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis.
	Read more about Doxycycline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5289	Capsule	Aldox 100 mg Capsule CAP 100 mg 10 x 10's	Capsule 51 RNW-PP-227497 ALDOX 100MG CAPSULE DOXYCYCLINE(AS DOXYCYCLINE HYCLATE) 100mg doxycycline base as doxycycline hyclate; Talc, starch. B4-5289 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 10 x 10 POM 1 12/9/2022 ALBEN HEALTH CARE INDUSTRIES LTD., ONITSHA AWKA ROAD, OGIDI ANAMBRA 8033332325 albenng@rocketmail.com Alben Healthcare Industries Limited, KM 15 Old Onitsha Awka Road ,Ogidi, Anambra State, Nigeria., Nigeria	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01AA02	Doxycycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5289